REVVITY, INC Interest Expense
REVVITY, INC (RVTY) reported Interest Expense of $24.72 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-06.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2024-08-06
- REVVITY, INC interest expense for the quarter ending 2024-06-30 was $24.72M, a 4.96% decline year-over-year.
- REVVITY, INC interest expense for the quarter ending 2024-03-31 was $24.40M, a 7.30% increase year-over-year.
- REVVITY, INC interest expense for the quarter ending 2023-10-01 was $25.49M, a 1.72% decline year-over-year.
- REVVITY, INC interest expense for the quarter ending 2023-07-02 was $26.01M, a 4.13% decline year-over-year.
- REVVITY, INC interest expense for fiscal 2021 was $49.71M, a 21.87% decline from fiscal 2019.
- REVVITY, INC interest expense for fiscal 2019 was $63.63M, a 5.00% decline from fiscal 2018.
- REVVITY, INC interest expense for fiscal 2018 was $66.98M, a 52.43% increase from fiscal 2017.
- REVVITY, INC interest expense for fiscal 2017 was $43.94M, a 5.81% increase from fiscal 2017.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|---|---|
| 2024-06-30 | $24.72M 10-Q · filed 2024-08-06 | $49.11M 10-Q · filed 2024-08-06 | ||||
| 2024-03-31 | $24.40M 10-Q · filed 2024-05-07 | |||||
| 2023-10-01 | $25.49M 10-Q · filed 2023-11-07 | $51.49M derived: sum of 2 quarters · filed 2024-08-06 | $74.23M 10-Q · filed 2023-11-07 | |||
| 2023-07-02 | $26.01M 10-Q · filed 2024-08-06 | $48.74M 10-Q · filed 2024-08-06 | ||||
| 2023-04-02 | $22.74M 10-Q · filed 2024-05-07 | |||||
| 2022-10-02 | $25.93M 10-Q · filed 2023-11-07 | $53.06M derived: sum of 2 quarters · filed 2023-11-07 | $81.45M 10-Q · filed 2023-11-07 | |||
| 2022-07-03 | $27.13M 10-Q · filed 2023-08-09 | $55.52M 10-Q · filed 2023-08-09 | ||||
| 2022-04-03 | $28.39M 10-Q · filed 2023-05-12 | |||||
| 2021-10-03 | $43.53M 10-Q · filed 2022-11-14 | $60.28M derived: sum of 2 quarters · filed 2022-11-14 | $74.41M 10-Q · filed 2022-11-14 | $86.81M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-07-04 | $16.75M 10-Q · filed 2022-08-09 | $30.88M 10-Q · filed 2022-08-09 | $43.28M derived: sum of 3 quarters · filed 2022-08-09 | $55.34M derived: sum of 4 quarters · filed 2022-08-09 | ||
| 2021-04-04 | $14.13M 10-Q · filed 2022-05-10 | $26.53M derived: sum of 2 quarters · filed 2022-05-10 | $38.59M derived: sum of 3 quarters · filed 2022-05-10 | $50.17M derived: sum of 4 quarters · filed 2022-05-10 | ||
| 2021-01-03 | $12.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $24.46M derived: sum of 2 quarters · filed 2021-11-09 | $36.05M derived: sum of 3 quarters · filed 2021-11-09 | $49.71M 10-K · filed 2021-03-02 | ||
| 2020-10-04 | $12.06M 10-Q · filed 2021-11-09 | $23.64M derived: sum of 2 quarters · filed 2021-11-09 | $37.31M 10-Q · filed 2021-11-09 | $51.73M derived: sum of 4 quarters · filed 2021-11-09 | ||
| 2020-07-05 | $11.59M 10-Q · filed 2021-08-10 | $25.25M 10-Q · filed 2021-08-10 | $39.67M derived: sum of 3 quarters · filed 2021-08-10 | $55.82M derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-04-05 | $13.66M 10-Q · filed 2021-05-11 | $28.09M derived: sum of 2 quarters · filed 2021-05-11 | $44.23M derived: sum of 3 quarters · filed 2021-05-11 | $61.44M derived: sum of 4 quarters · filed 2021-05-11 | ||
| 2019-12-29 | $14.42M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $30.57M derived: sum of 2 quarters · filed 2021-03-02 | $47.78M derived: sum of 3 quarters · filed 2021-03-02 | $63.63M 10-K · filed 2021-03-02 | ||
| 2019-09-29 | $16.15M 10-Q · filed 2020-11-10 | $33.36M derived: sum of 2 quarters · filed 2020-11-10 | $49.21M 10-Q · filed 2020-11-10 | $65.44M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2019-06-30 | $17.21M 10-Q · filed 2020-08-11 | $33.06M 10-Q · filed 2020-08-11 | $49.29M derived: sum of 3 quarters · filed 2021-03-02 | $65.97M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2019-03-31 | $15.85M 10-Q · filed 2020-05-12 | $32.08M derived: sum of 2 quarters · filed 2021-03-02 | $48.77M derived: sum of 3 quarters · filed 2021-03-02 | $65.18M derived: sum of 4 quarters · filed 2021-03-02 | ||
| 2018-12-30 | $16.23M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-02 | $32.91M derived: sum of 2 quarters · filed 2021-03-02 | $49.33M derived: sum of 3 quarters · filed 2021-03-02 | $66.98M 10-K · filed 2021-03-02 | ||
| 2018-09-30 | $16.68M 10-Q · filed 2019-11-05 | $33.09M derived: sum of 2 quarters · filed 2019-11-05 | $50.74M 10-Q · filed 2019-11-05 | $62.17M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-07-01 | $16.41M 10-Q · filed 2019-08-06 | $34.06M 10-Q · filed 2019-08-06 | $45.49M derived: sum of 3 quarters · filed 2020-02-25 | $56.47M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-04-01 | $17.65M 10-Q · filed 2019-05-07 | $29.08M derived: sum of 2 quarters · filed 2020-02-25 | $40.05M derived: sum of 3 quarters · filed 2020-02-25 | $50.73M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2017-12-31 | $11.43M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $22.40M derived: sum of 2 quarters · filed 2020-02-25 | $33.08M derived: sum of 3 quarters · filed 2020-02-25 | $43.94M 10-K · filed 2020-02-25 | ||
| 2017-10-01 | $10.97M 10-Q · filed 2018-11-06 | $21.65M derived: sum of 2 quarters · filed 2018-11-06 | $32.51M 10-Q · filed 2018-11-06 | $43.26M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-07-02 | $10.67M 10-Q · filed 2018-08-07 | $21.54M 10-Q · filed 2018-08-07 | $32.29M derived: sum of 3 quarters · filed 2019-02-26 | $43.28M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-04-02 | $10.86M 10-Q · filed 2018-05-08 | $21.61M derived: sum of 2 quarters · filed 2019-02-26 | $32.61M derived: sum of 3 quarters · filed 2019-02-26 | $42.55M derived: sum of 4 quarters · filed 2019-02-26 | ||
| 2017-01-01 | $10.75M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $21.75M derived: sum of 2 quarters · filed 2019-02-26 | $31.69M derived: sum of 3 quarters · filed 2019-02-26 | $41.53M 10-K · filed 2019-02-26 | ||
| 2016-10-02 | $11.00M 10-Q · filed 2017-11-07 | $20.94M derived: sum of 2 quarters · filed 2017-11-07 | $30.78M 10-Q · filed 2017-11-07 | $40.21M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-07-03 | $9.94M 10-Q · filed 2017-08-08 | $19.78M 10-Q · filed 2017-08-08 | $29.21M derived: sum of 3 quarters · filed 2018-02-27 | $39.09M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-04-03 | $9.84M 10-Q · filed 2017-05-09 | $19.27M derived: sum of 2 quarters · filed 2018-02-27 | $29.15M derived: sum of 3 quarters · filed 2018-02-27 | $38.45M derived: sum of 4 quarters · filed 2018-02-27 | ||
| 2016-01-03 | $9.43M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $19.31M derived: sum of 2 quarters · filed 2018-02-27 | $28.61M derived: sum of 3 quarters · filed 2018-02-27 | $38.00M 10-K · filed 2018-02-27 | ||
| 2015-10-04 | $9.87M 10-Q · filed 2016-11-08 | $19.18M derived: sum of 2 quarters · filed 2016-11-08 | $28.56M 10-Q · filed 2016-11-08 | $37.63M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-28 | $9.30M 10-Q · filed 2016-08-09 | $18.69M 10-Q · filed 2016-08-09 | $27.75M derived: sum of 3 quarters · filed 2017-02-28 | $36.66M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-03-29 | $9.39M 10-Q · filed 2016-05-10 | $18.45M derived: sum of 2 quarters · filed 2017-02-28 | $27.36M derived: sum of 3 quarters · filed 2017-02-28 | $36.44M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2014-12-28 | $9.06M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $17.97M derived: sum of 2 quarters · filed 2017-02-28 | $27.05M derived: sum of 3 quarters · filed 2017-02-28 | $36.27M 10-K · filed 2017-02-28 | ||
| 2014-09-28 | $8.91M 10-Q · filed 2015-11-10 | $17.99M derived: sum of 2 quarters · filed 2015-11-10 | $27.21M 10-Q · filed 2015-11-10 | $41.82M derived: sum of 4 quarters · filed 2016-03-01 | ||
| 2014-06-29 | $9.08M 10-Q · filed 2015-08-04 | $18.30M 10-Q · filed 2015-08-04 | $32.91M derived: sum of 3 quarters · filed 2016-03-01 | $44.62M derived: sum of 4 quarters · filed 2016-03-01 | ||
| 2014-03-30 | $9.22M 10-Q · filed 2015-05-05 | $23.83M derived: sum of 2 quarters · filed 2016-03-01 | $35.54M derived: sum of 3 quarters · filed 2016-03-01 | $47.45M derived: sum of 4 quarters · filed 2016-03-01 | ||
| 2013-12-29 | $14.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $26.32M derived: sum of 2 quarters · filed 2016-03-01 | $38.23M derived: sum of 3 quarters · filed 2016-03-01 | $49.92M 10-K · filed 2016-03-01 | ||
| 2013-09-29 | $11.70M 10-Q · filed 2014-11-04 | $23.62M derived: sum of 2 quarters · filed 2014-11-04 | $35.31M 10-Q · filed 2014-11-04 | $46.96M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-06-30 | $11.91M 10-Q · filed 2014-08-05 | $23.61M 10-Q · filed 2014-08-05 | $35.26M derived: sum of 3 quarters · filed 2015-02-24 | $46.62M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2013-03-31 | $11.69M 10-Q · filed 2014-05-06 | $23.34M derived: sum of 2 quarters · filed 2015-02-24 | $34.70M derived: sum of 3 quarters · filed 2015-02-24 | $46.04M derived: sum of 4 quarters · filed 2015-02-24 | ||
| 2012-12-30 | $11.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $23.01M derived: sum of 2 quarters · filed 2015-02-24 | $34.35M derived: sum of 3 quarters · filed 2015-02-24 | $45.79M 10-K · filed 2015-02-24 | ||
| 2012-09-30 | $11.36M 10-Q · filed 2013-11-05 | $22.70M derived: sum of 2 quarters · filed 2013-11-05 | $34.14M 10-Q · filed 2013-11-05 | $46.34M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-07-01 | $11.34M 10-Q · filed 2013-08-06 | $22.78M 10-Q · filed 2013-08-06 | $34.98M derived: sum of 3 quarters · filed 2014-02-25 | $39.43M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-04-01 | $11.44M 10-Q · filed 2013-05-06 | $23.64M derived: sum of 2 quarters · filed 2014-02-25 | $28.09M derived: sum of 3 quarters · filed 2014-02-25 | $32.30M derived: sum of 4 quarters · filed 2014-02-25 | ||
| 2012-01-01 | $12.21M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $16.65M derived: sum of 2 quarters · filed 2014-02-25 | $20.87M derived: sum of 3 quarters · filed 2014-02-25 | $24.78M 10-K · filed 2014-02-25 | ||
| 2011-10-02 | $4.45M 10-Q · filed 2012-11-06 | $8.66M derived: sum of 2 quarters · filed 2012-11-06 | $12.58M 10-Q · filed 2012-11-06 | $16.53M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-07-03 | $4.21M 10-Q · filed 2012-08-07 | -$4.21M 10-Q · filed 2011-08-10 | $8.13M 10-Q · filed 2012-08-07 | -$8.13M 10-Q · filed 2011-08-10 | $12.08M derived: sum of 3 quarters · filed 2013-02-26 | $16.27M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-04-03 | $3.92M 10-Q · filed 2012-05-08 | $7.87M derived: sum of 2 quarters · filed 2013-02-26 | $12.05M derived: sum of 3 quarters · filed 2013-02-26 | $8.11M derived: sum of 4 quarters · filed 2013-02-26 | ||
| 2011-01-02 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $8.14M derived: sum of 2 quarters · filed 2013-02-26 | $4.19M derived: sum of 3 quarters · filed 2013-02-26 | $15.89M 10-K · filed 2013-02-26 | ||
| 2010-10-03 | $4.18M 10-Q · filed 2011-11-04 | $236.00K derived: sum of 2 quarters · filed 2011-11-04 | $11.94M 10-Q · filed 2011-11-04 | |||
| 2010-07-04 | -$3.95M 10-Q · filed 2011-08-10 | -$7.75M 10-Q · filed 2011-08-10 | ||||
| 2010-01-03 | $16.01M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |